Takeda Pharmaceuticals North America, Inc., and Takeda Pharmaceuticals Europe Limited, recently issued a joint response regarding the decision taken by the US Food and Drug Administration (FDA) to restrict the use of the drug Avandia (rosiglitazone), in order to allay any fears in patients who were being treated with drugs containing Pioglitazone. Pioglitazone is a [...]

The U.S. Food and Drug Administration (FDA) recently announced its decision to restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who are unable to control their diabetes using any other medications. This decision was made by the FDA following the results of studies which indicated that the use [...]

The UK’s biggest pharmaceuticals company, GlaxoSmithKline (NYSE:GSK) recently issued a response to an article published in the British Medical Journal (BMJ), regarding the safety of a drug produced by GSK used in the treatment of diabetes, known as rosiglitazone, and sold under the brand name Avandia. Fiona Godlee, The Editor-In-Chief of the BMJ had opined [...]

A medical panel has recommended to the FDA that popular diabetes drug Avandia be withdrawn completely off the market, or have its sales severely restricted. Avandia is manufactured by GlaxoSmithKline, and it’s the trade name for the chemical drug rosiglitazone.  Avandia is used by many diabetic patients as it helps their bodies become more sensitive [...]